Case Report
COVID-19 Mortality in a Pediatric Patient with Hemoglobin SC Disease and Alpha-Thalassemia Trait
Table 1
Notable lab values. Peak (or nadir) noted as clinically relevant and values on day of arrest.
| | Lab | Peak (nadir) | Day of arrest | Reference (units) |
| | Procalcitonin (on presentation, not repeated) | 0.31 | — | ≤0.08 (ng/mL) | | C-reactive protein | 127 | — | 0.00-10.00 (mg/L) | | Ferritin (on presentation, not repeated) | 250 | — | 30.0-400.0 (ng/mL) | | D-dimer | >20.00 | 18.21 | ≤0.80 (μg/mL FEU) | | Fibrinogen | 458 | 458 | 191–430 (mg/dL) | | International normalization ratio | 1.7 | 1.3 | 0.9–1.1 | | Partial thromboplastin time | 52.8 | 44.8 | 23.9–34.7 (seconds) | | White blood cell count | 26.9 | 23.54 | 3.84–9.84 (×10-3/μL) | | Band | 24% | 0% | 0–0 (%) | | Lymphocytes | 6% (nadir) | 11.1% | 16.4-52.7 (%) | | Neutrophils | 77% | 76.4% | 32.5–74.5 (%) | | Monocytes | 3% (nadir) | 11.1% | 4.4–12.3 (%) | | Eosinophils | 0.1% | 0% | 0.0–4.0 (%) | | Basophils | 1% | 0.1 | 0.0–0.7 (%) | | Hemoglobin | 8 (nadir) | 8 | (g/dL) | | Platelets | 36 (nadir) | 126 | 175–332 (×103/μL) | | Partial thromboplastin time | 52.8 | 44.8 | 23.9–34.7 seconds | | Creatinine (baseline 0.66) | 1.6 | 1.33 | 0.60-1.00 mg/dL | | Interleukin-18 | 757 | — | 89-540 pg/mL | | CXCL9 | 136 | — | ≤121 pg/mL | | Interleukin-6 | 78.7 | — | ≤5 pg/mL | | Interleukin-10 | 59 | — | ≤18 pg/mL | | Creatine kinase | 950 | — | 64.0-499.0 U/L | | Troponin-T | 6 | — | ≤22 ng/L |
|
|
